Earnings · China A-shares
Zhejiang Huahai Pharmaceutical Co., Ltd. Class A (600521) earnings
Zhejiang Huahai Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-29: net profit +178.61% year on year, +159.96% excluding one-off items. Wave Radar's earnings-quality score is 90 of 100 (Sound). The stock moved +3.84% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-29
- Period end
- 2026-09-30
- Net profit YoY
- +178.61%
- Excl. one-offs YoY
- +159.96%
- Net profit QoQ
- -21.25%
- Result
- Great
- Quality score
- 90
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +2.26% | — |
| 3 days | +3.84% | — |
| 7 days | +8.93% | — |
| 14 days | +3.65% | — |
Report history
Over the last 8 reports, net profit grew year on year in 5 of them. The stock rose in the 3 trading days after 2 of 6 reports (average -0.25%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-30 | ¥1.06B | +178.61% | +159.96% | +15.86% | 0.71 | 10.80% | +3.84% | — | — |
| 2026 interim report | 2026-08-27 | ¥770.91M | +88.26% | +17.31% | +8.78% | 0.52 | 7.92% | -1.77% | +0.55% | +9.48% |
| 2026 Q1 report | 2026-04-30 | ¥404.18M | +35.90% | -52.19% | -1.40% | 0.27 | 4.19% | +2.37% | -8.50% | -10.55% |
| 2025 annual report | 2026-04-30 | ¥266.40M | -76.19% | -86.05% | -10.06% | 0.18 | 2.86% | +2.37% | -8.50% | -10.55% |
| 2025 Q3 report | 2025-10-31 | ¥380.36M | -63.12% | -73.85% | -11.57% | 0.26 | 4.01% | -1.92% | -5.91% | -1.23% |
| 2025 interim report | 2025-08-26 | ¥409.49M | -45.30% | -52.48% | -11.93% | 0.28 | 4.35% | -3.26% | -15.32% | -17.00% |
| 2025 Q1 report | 2025-04-30 | ¥297.40M | +9.81% | -9.80% | -5.21% | 0.21 | 3.29% | -0.76% | +43.25% | +40.08% |
| 2024 annual report | 2025-04-30 | ¥1.12B | +34.74% | +27.10% | +14.91% | 0.77 | 13.24% | -0.76% | +43.25% | +40.08% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.